Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy

A report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancer

Andrew Zloza, A. Karolina Palucka, Lisa Coussens, Philip J. Gotwals, Mark B. Headley, Elizabeth M. Jaffee, Amanda Lund, Arlene H. Sharpe, Mario Sznol, Derek A. Wainwright, Kwok Kin Wong, Marcus W. Bosenberg

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Understanding how murine models can elucidate the mechanisms underlying antitumor immune responses and advance immune-based drug development is essential to advancing the field of cancer immunotherapy. The Society for Immunotherapy of Cancer (SITC) convened a workshop titled, "Challenges, Insights, and Future Directions for Mouse and Humanized Models in Cancer Immunology and Immunotherapy" as part of the SITC 31st Annual Meeting and Associated Programs on November 10, 2016 in National Harbor, MD. The workshop focused on key issues in optimizing models for cancer immunotherapy research, with discussions on the strengths and weaknesses of current models, approaches to improve the predictive value of mouse models, and advances in cancer modeling that are anticipated in the near future. This full-day program provided an introduction to the most common immunocompetent and humanized models used in cancer immunology and immunotherapy research, and addressed the use of models to evaluate immune-targeting therapies. Here, we summarize the workshop presentations and subsequent panel discussion.

Original languageEnglish (US)
Article number77
JournalJournal for ImmunoTherapy of Cancer
Volume5
Issue number1
DOIs
StatePublished - Sep 19 2017

Fingerprint

Allergy and Immunology
Immunotherapy
Education
Neoplasms
Direction compound
Research
Pharmaceutical Preparations

Keywords

  • Cancer immunotherapy
  • Humanized mouse
  • Immunocompetent
  • Mouse models
  • Mouse-in-mouse
  • Tumor microenvironment

ASJC Scopus subject areas

  • Oncology
  • Immunology and Allergy
  • Cancer Research
  • Molecular Medicine
  • Pharmacology
  • Immunology

Cite this

Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy : A report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancer. / Zloza, Andrew; Karolina Palucka, A.; Coussens, Lisa; Gotwals, Philip J.; Headley, Mark B.; Jaffee, Elizabeth M.; Lund, Amanda; Sharpe, Arlene H.; Sznol, Mario; Wainwright, Derek A.; Wong, Kwok Kin; Bosenberg, Marcus W.

In: Journal for ImmunoTherapy of Cancer, Vol. 5, No. 1, 77, 19.09.2017.

Research output: Contribution to journalArticle

Zloza, Andrew ; Karolina Palucka, A. ; Coussens, Lisa ; Gotwals, Philip J. ; Headley, Mark B. ; Jaffee, Elizabeth M. ; Lund, Amanda ; Sharpe, Arlene H. ; Sznol, Mario ; Wainwright, Derek A. ; Wong, Kwok Kin ; Bosenberg, Marcus W. / Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy : A report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancer. In: Journal for ImmunoTherapy of Cancer. 2017 ; Vol. 5, No. 1.
@article{fd38cfad69f94bbaa8b220d91ad0c9f6,
title = "Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy: A report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancer",
abstract = "Understanding how murine models can elucidate the mechanisms underlying antitumor immune responses and advance immune-based drug development is essential to advancing the field of cancer immunotherapy. The Society for Immunotherapy of Cancer (SITC) convened a workshop titled, {"}Challenges, Insights, and Future Directions for Mouse and Humanized Models in Cancer Immunology and Immunotherapy{"} as part of the SITC 31st Annual Meeting and Associated Programs on November 10, 2016 in National Harbor, MD. The workshop focused on key issues in optimizing models for cancer immunotherapy research, with discussions on the strengths and weaknesses of current models, approaches to improve the predictive value of mouse models, and advances in cancer modeling that are anticipated in the near future. This full-day program provided an introduction to the most common immunocompetent and humanized models used in cancer immunology and immunotherapy research, and addressed the use of models to evaluate immune-targeting therapies. Here, we summarize the workshop presentations and subsequent panel discussion.",
keywords = "Cancer immunotherapy, Humanized mouse, Immunocompetent, Mouse models, Mouse-in-mouse, Tumor microenvironment",
author = "Andrew Zloza and {Karolina Palucka}, A. and Lisa Coussens and Gotwals, {Philip J.} and Headley, {Mark B.} and Jaffee, {Elizabeth M.} and Amanda Lund and Sharpe, {Arlene H.} and Mario Sznol and Wainwright, {Derek A.} and Wong, {Kwok Kin} and Bosenberg, {Marcus W.}",
year = "2017",
month = "9",
day = "19",
doi = "10.1186/s40425-017-0278-6",
language = "English (US)",
volume = "5",
journal = "Journal for ImmunoTherapy of Cancer",
issn = "2051-1426",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy

T2 - A report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancer

AU - Zloza, Andrew

AU - Karolina Palucka, A.

AU - Coussens, Lisa

AU - Gotwals, Philip J.

AU - Headley, Mark B.

AU - Jaffee, Elizabeth M.

AU - Lund, Amanda

AU - Sharpe, Arlene H.

AU - Sznol, Mario

AU - Wainwright, Derek A.

AU - Wong, Kwok Kin

AU - Bosenberg, Marcus W.

PY - 2017/9/19

Y1 - 2017/9/19

N2 - Understanding how murine models can elucidate the mechanisms underlying antitumor immune responses and advance immune-based drug development is essential to advancing the field of cancer immunotherapy. The Society for Immunotherapy of Cancer (SITC) convened a workshop titled, "Challenges, Insights, and Future Directions for Mouse and Humanized Models in Cancer Immunology and Immunotherapy" as part of the SITC 31st Annual Meeting and Associated Programs on November 10, 2016 in National Harbor, MD. The workshop focused on key issues in optimizing models for cancer immunotherapy research, with discussions on the strengths and weaknesses of current models, approaches to improve the predictive value of mouse models, and advances in cancer modeling that are anticipated in the near future. This full-day program provided an introduction to the most common immunocompetent and humanized models used in cancer immunology and immunotherapy research, and addressed the use of models to evaluate immune-targeting therapies. Here, we summarize the workshop presentations and subsequent panel discussion.

AB - Understanding how murine models can elucidate the mechanisms underlying antitumor immune responses and advance immune-based drug development is essential to advancing the field of cancer immunotherapy. The Society for Immunotherapy of Cancer (SITC) convened a workshop titled, "Challenges, Insights, and Future Directions for Mouse and Humanized Models in Cancer Immunology and Immunotherapy" as part of the SITC 31st Annual Meeting and Associated Programs on November 10, 2016 in National Harbor, MD. The workshop focused on key issues in optimizing models for cancer immunotherapy research, with discussions on the strengths and weaknesses of current models, approaches to improve the predictive value of mouse models, and advances in cancer modeling that are anticipated in the near future. This full-day program provided an introduction to the most common immunocompetent and humanized models used in cancer immunology and immunotherapy research, and addressed the use of models to evaluate immune-targeting therapies. Here, we summarize the workshop presentations and subsequent panel discussion.

KW - Cancer immunotherapy

KW - Humanized mouse

KW - Immunocompetent

KW - Mouse models

KW - Mouse-in-mouse

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85029614355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029614355&partnerID=8YFLogxK

U2 - 10.1186/s40425-017-0278-6

DO - 10.1186/s40425-017-0278-6

M3 - Article

VL - 5

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

SN - 2051-1426

IS - 1

M1 - 77

ER -